Dutch biotech Kiadis Pharma appointed Ray Barlow as chief business officer. Barlow most recently led UK-based data-driven drug discovery company E-therapeutics as its CEO. His prior roles include serving at Amgen (NASDAQ: AMGN) as executive director of corporate development and at Crucell Vaccines, a Netherlands-based company that’s now a subsidiary of Johnson & Johnson (NASDAQ: JNJ).
Kiadis, a clinical-stage firm, is developing cell therapies based on natural killer cells to treat cancers.
Sponsored · Webinar
How Functional Cell-based Assays Support Clinical Programs Managing Proinflammatory Cytokines Associated with High Mortality
Eurofins DiscoverX
From Our Partners · Special Report
Advice for funding and future transformational opportunities
From Our Editors · Special Report
Becoming the Cell & Gene Therapy Hub
